Vaccination
Vaccination is a preventive medical intervention that prepares the immune system to recognize and respond to a specific infectious agent without requiring the individual to experience the disease itself.
Vaccination is a preventive medical intervention that prepares the immune system to recognize and respond to a specific infectious agent without requiring the individual to experience the disease itself. Vaccines may contain weakened or inactivated microorganisms, purified antigens, genetic instructions such as messenger RNA, viral vectors, or other antigen-delivery systems. These components stimulate innate and adaptive immune responses, including the production of antigen-specific antibodies and memory B and T cells. On subsequent exposure to the corresponding pathogen, this immunological memory can reduce the probability of infection, limit disease severity, and decrease the risk of complications and death.
Vaccination is used against numerous viral and bacterial infections, including COVID-19 caused by SARS-CoV-2, influenza, respiratory syncytial virus (RSV), human papilloma virus, herpes zoster, and pneumococcal disease. Its effects can extend beyond directly vaccinated individuals when sufficiently high population coverage reduces transmission, although protection depends on vaccine characteristics, pathogen evolution, Age, immune status, timing, and vaccination status. vaccine-induced protection may be particularly important for children, older adults, pregnant women, and adults with clinical risk factors. vaccine hesitancy, unequal access, delayed doses, and interruptions in vaccine deployment can reduce coverage and weaken these individual and population-level benefits.
- Increased risk of corneal transplant rejection following SARS-CoV-2 infection and vaccination. PMID 42714722
- Mathematical modeling of HBV-HDV transmission with superinfection: The role of vaccination and liver transplantation in disease dynamics. PMID 42715288
Where the papers sit
11 papers study vaccination directly. Those 11 do not group into themes. Population modeling, safety surveillance, vaccine design, and economic evaluation appear together across HBV-HDV, COVID-19, malaria, RSV, and respiratory disease, without a shared biological question or clear direction. They are no more alike than papers drawn from anywhere in the corpus. 1 paradigm shift follows.
Vaccination is not uniformly protective: it can be associated with post-vaccination harm that routine cohort comparisons may obscure
The study of COVID-19 vaccination and corneal transplant rejection found that vaccination within three months was associated with elevated rejection risk, while the Qatar study of stroke incidence after COVID-19 vaccination found a seemingly protective cohort association that its authors judged potentially spurious and inconsistent with self-controlled case-series evidence, warning that cohort designs may underestimate rare vaccine adverse events 42714722Sep 42635361Aug. Together, these findings replace the assumption that vaccination outcomes can be treated as straightforwardly beneficial or that conventional cohort estimates reliably exclude rare harms: vaccination may coincide with clinically important adverse outcomes, and the study design can determine whether that signal is visible.
Recent Findings on vaccination
Population Immunization Research: Vaccination coverage and timing strongly influence modeled transmission, with timely vaccination reducing COVID-19 spread and coverage and efficacy lowering HBV-HDV reproduction. 42715288Sep42686793Sep Seasonal models favor concentrated, time-varying vaccination, while pulse components appear when transmission has upward jump discontinuities; vaccination and mask-wearing associations can also determine epidemic outcomes. 42684562Sep42276297Jun Economic evaluations support expanding adult respiratory immunization, especially RSV vaccination for immunocompromised adults, and increasing uptake for pneumococcal disease, influenza, RSV, and COVID-19. 42535735Jul42484014Jul Safety estimates remain sensitive to study design: COVID-19 vaccination was associated with corneal transplant rejection, whereas cohort analysis of stroke suggested protection that contrasted with self-controlled case series findings indicating a small increased risk. 42714722Sep42635361Aug Surveillance results were more consistent for influenza, as alternative test-negative design assumptions produced overlapping vaccine-effectiveness estimates. 42053054Apr Vaccine development is broadening antigenic targets, while population programs continue assessing vaccination coverage and delayed childhood vaccination across low-income and middle-income countries. 42565808Aug42035756Apr
Written from 11 PubMed abstracts, each one cited by PMID above. Published: 2026-08-20. Last written: 2026-09-11 by GPT. Drafted by language models from published abstracts; not medical advice.